A Case Report of Statin-Induced Immune-Mediated Necrotizing Myopathy Treatment Challenges.
Anwar I JoudehMhd Kutaiba AlbuniSara Seife HassenPhool IqbalElsaid Mohamed Aziz BedairSalah MahdiPublished in: Case reports in rheumatology (2022)
Statin-induced necrotizing autoimmune myopathy is an immune-mediated necrotizing myopathy related to the use of statins. It is a very rare disease, which usually presents with proximal muscle weakness and frank elevation in creatine kinase levels. Stopping statin and the use of immunosuppressive therapy are considered the mainstay therapy. Use of steroids in patients with inflammatory myopathy can be complicated by steroid-induced myopathy. Herein, we present a case of a 55-year-old patient with statin-induced necrotizing autoimmune myopathy based on the presence of proximal muscle weakness, magnetic resonance findings, suggestive muscle biopsy features, and positive anti-HMGCR autoantibodies. The patient was treated with triple immunosuppressive therapy with a particularly good response to intravenous immunoglobulin. This report highlights the importance of timely diagnosis and early use of combined immunosuppressive therapy to improve patients' outcome affected by this rare disease.
Keyphrases
- late onset
- high glucose
- cardiovascular disease
- magnetic resonance
- diabetic rats
- drug induced
- coronary artery disease
- skeletal muscle
- muscular dystrophy
- multiple sclerosis
- oxidative stress
- end stage renal disease
- chronic kidney disease
- case report
- systemic lupus erythematosus
- high dose
- early onset
- endothelial cells
- bone marrow
- stress induced